| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.6M | +15.8% |
| Cost of Revenue | $43.0M | +10.2% |
| Gross Profit | $15.6M | +34.6% |
| R&D Expense | $3.0M | -45.3% |
| SG&A Expense | $23.0M | +4.9% |
| Operating Income | -$23.2M | +10.0% |
| Pre-tax Income | -$70.0M | -72.4% |
| Income Tax | -$94K | — |
| Net Income | -$69.9M | -72.2% |
| EPS (Basic) | -$14.80 | -150.4% |
| EPS (Diluted) | -$14.80 | -150.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.3M | +276.8% |
| Accounts Receivable | $4.2M | +74.5% |
| Inventory | $24.2M | +11.6% |
| Current Assets | $50.2M | +52.4% |
| Total Assets | $86.5M | +15.1% |
| Current Liabilities | $19.8M | -9.6% |
| Long-term Debt | $19.3M | -77.5% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.0M | -261.6% |
| Capital Expenditures | $1.9M | -28.8% |
| Investing Cash Flow | -$1.9M | +28.6% |
| Financing Cash Flow | $41.3M | +1919.4% |
| Free Cash Flow | -$27.9M | -181.4% |
| $52.8M |
| -37.6% |
| Stockholders' Equity | $11.5M | +222.6% |